A Smart Metal–Organic Framework Nanomaterial for Lung Targeting

Despite high morbidity and mortality associated with lung diseases, addressing drugs towards lung tissue remains a pending task. Particle lung filtration has been proposed for passive lung targeting and drug delivery. However, toxicity issues derived from the long‐term presence of the particles must be overcome. By exploiting some of the ignored properties of nanosized metal–organic frameworks it is possible to achieve impressive antitumoral effects on experimental lung tumors, even without the need to engineer the surface of the material. In fact, it was discovered that, based on unique pH‐responsiveness and reversible aggregation behaviors, nanoMOF was capable of targeting lung tissue. At the neutral pH of the blood, the nanoMOFs form aggregates with the adequate size to be retained in lung capillaries. Within 24 h they then disaggregate and release their drug payload. This phenomenon was compatible with lung tissue physiology.     

Conjugated Polymer Nanoparticles with Appended Photo‐Responsive Units for Controlled Drug Delivery,Release, and Imaging

Carriers that can afford tunable physical and structural changes are envisioned to address critical issues in controlled drug delivery applications. Herein, photo‐responsive conjugated polymer nanoparticles (CPNs) functionalized with donor–acceptor Stenhouse adduct (DASA) and folic acid units for controlled drug delivery and imaging are reported. Upon visible‐light (λ=550 nm) irradiation, CPNs simultaneously undergo structure, color, and polarity changes that release encapsulated drugs into the cells. The backbone of CPNs favors FRET to DASA units boosting their fluorescence. Notably, drug‐loaded CPNs exhibit excellent biocompatibility in the dark, indicating perfect control of the light trigger over drug release. Delivery of both hydrophilic and hydrophobic drugs with good loading efficiency was demonstrated. This strategy enables remotely controlled drug delivery with visible‐light irradiation, which sets an example for designing delivery vehicles for non‐invasive therapeutics.     

Dynamic Calcium Metal–Organic Framework Acts as a Selective Organic Solvent Sponge

Herein, we present a Ca‐based metal–organic framework named AEPF‐1, which is an active and selective catalyst in olefin hydrogenation reactions. AEPF‐1 exhibits a phase transition upon desorption of guest molecules. This structural transformation takes place by a crystal to crystal transformation accompanied by the loss of single‐crystal integrity. Powder diffraction methods and computational studies were applied to determine the structure of the guest‐free phase. This work also presents data on the exceptional adsorption behavior of this material, which is shown to be capable of separating polar from nonpolar organic solvents, and is a good candidate for selective solvent adsorption under mild conditions.     

Enhanced Drug Delivery by Dissolution of Amorphous Drug Encapsulated in a Water Unstable Metal–Organic Framework (MOF)

Encapsulating a drug molecule into a water‐reactive metal–organic framework (MOF) leads to amorphous drug confined within the nanoscale pores. Rapid release of drug occurs upon hydrolytic decomposition of MOF in dissolution media. Application to improve dissolution and solubility for the hydrophobic small drug molecules curcumin, sulindac, and triamterene is demonstrated. The drug@MOF composites exhibit significantly enhanced dissolution and achieves high supersaturation in simulated gastric and/or phosphate buffer saline media. This combination strategy where MOF inhibits crystallization of the amorphous phase and then releases drug upon MOF irreversible structural collapse represents a novel and generalizable approach for drug delivery of poorly soluble compounds while overcoming the traditional weakness of amorphous drug delivery: physical instability of the amorphous form.     

Fluorous Phase‐Directed Peptide Assembly Affords Nano‐Peptisomes Capable of Ultrasound‐Triggered Cellular Delivery

Here, we report the design, synthesis and efficacy of a new class of ultrasound (US)‐sensitive self‐assembled peptide‐based nanoparticle. Peptisomes are prepared via templated assembly of a de novo designed peptide at the interface of fluorinated nanodroplets. Utilizing peptide assembly allows for facile particle synthesis, direct incorporation of bioactive sequences displayed from the particle corona, and the ability to easily encapsulate biologics during particle preparation using a mild solvent exchange procedure. Further, nano‐peptisome size can be precisely controlled by simply modulating the starting peptide and fluorinated solvent concentrations during synthesis. Biomolecular cargo encapsulated within the particle core can be directly delivered to the cytoplasm of cells upon US‐mediated rupture of the carrier. Thus, nano‐peptisomes represent a novel class of US‐activated carriers that can shuttle cell‐impermeable biomacromolecules into cells with spatial and temporal precision.     

Release of Amino‐ or Carboxy‐Containing Compounds Triggered by HOCl: Application for Imaging and Drug Design

The overproduction of HOCl is highly correlated with diseases such as atherosclerosis, rheumatoid arthritis, and cancer. Whilst acting as a marker of these diseases, HOCl might also be used as an activator of prodrugs or drug delivery systems for the treatment of the corresponding disease. In this work, a new platform of HOCl probes has been developed that integrates detection, imaging, and therapeutic functions. The probes can detect HOCl, using both NIR emission and the naked eye in vitro, with high sensitivity and selectivity at ultralow concentrations (the detection limit is at the nanomolar level). Basal levels of HOCl can be imaged in HL‐60 cells without special stimulation. Moreover, the probes provided by this platform can rapidly release either amino‐ or carboxy‐containing compounds from prodrugs, during HOCl detection and imaging, to realize a therapeutic effect.     

Solvent Molecule Controlled Zinc(II) Metal‐Organic Frameworks with Different Topology

Two zinc(II) coordination polymers, namely [Zn₂(bptc)(DMF)₂(H₂O)]_n ( 1 ) and [Zn(bptc)_0.5(DMA)]_n ( 2 ) (H₄bptc = biphenyl‐3,3′,5,5′‐tetracarboxylic acid, DMF = N,N′‐dimethylformamide, DMA = N,N′‐dimethylacetamide), were obtained under solvothermal conditions by varying the reaction solvents. Single crystal X‐ray diffraction analyses revealed that compound 1 features a 3D PtS type framework based on dinuclear [Zn₂O(COO)₂] subunits and compound 2 features a 3D lvt type framework based on paddle‐wheel shaped [Zn₂(COO)₄] subunits. Moreover, the luminescent and thermal stabilities of these two compounds were investigated.     

Construction of Flexible‐on‐Rigid Hybrid‐Phase Metal–Organic Frameworks for Controllable Multi‐Drug Delivery

Multi‐component MOFs contain multiple sets of unique and hierarchical pores, with different functions for different applications, distributed in their inter‐linked domains. Herein, we report the construction of a class of precisely aligned flexible‐on‐rigid hybrid‐phase MOFs with a unique rods‐on‐octahedron morphology. We demonstrated that hybrid‐phase MOFs can be constructed based on two prerequisites: the partially matched topology at the interface of the two frameworks, and the structural flexibility of MOFs with acs topology, which can compensate for the differences in lattice parameters. Furthermore, we achieved domain selective loading of multiple guest molecules into the hybrid‐phase MOF, as observed by scanning transmission electron microscopy–energy‐dispersive X‐ray spectrometry elemental mapping. Most importantly, we successfully applied the constructed hybrid‐phase MOF to develop a dual‐drug delivery system with controllable loading ratio and release kinetics.     

BioMOFs: Metal–Organic Frameworks for Biological and Medical Applications

The class of highly porous materials called metal–organic frameworks offer many opportunities for applications across biology and medicine. Their wide range of chemical composition makes toxicologically acceptable formulation possible, and their high level of functionality enables possible applications as imaging agents and as delivery vehicles for therapeutic agents. The challenges in the area encompass not only the development of new solids but also improvements in the formulation and processing of the materials, including tailoring the morphology and surface chemistry of the frameworks to fit the proposed applications.     

Solvent‐Induced Control over Breathing Behavior in Flexible Metal–Organic Frameworks for Natural‐Gas Delivery

Finding appropriate stimuli for controlling the breathing behavior of flexible metal–organic frameworks (MOFs) is highly challenging. Herein, we report the solvent‐induced changes in the particle size and stability of different breathing phases of the MIL‐53 series, a group of flexible MOFs. A water/dimethylformamide (DMF) ratio is tuned to synthesize members of the MIL‐53 series which have different behaviors. The breathing is explored by high‐pressure methane sorption tests. Increasing DMF concentration decreases MOF particle size and increases the stability of the porous phases, boosting the 5.8–65 bar sorption difference of methane, which is required for natural‐gas delivery.     

A Dual‐Targeted Organic Photothermal Agent for Enhanced Photothermal Therapy

The development of highly effective anticancer drugs that cause minimal damage to the surrounding normal tissues is a challenging topic in cancer therapy. Herein, we demonstrate a dual‐targeted organic molecule that functions as a photothermal agent by actively targeting tumor tissue and mitochondria to selectively kill cancer cells. The synthesized photothermal agent exhibited high photothermal conversion efficiency, low cytotoxicity, and good biological compatibility. In vivo experiments showed an excellent tumor inhibitory effect of the dual‐targeted photothermal agent.     

Metal‐Organic Frameworks as Platform for Lewis‐Acid‐Catalyzed Organic Transformations

Metal‐organic frameworks (MOFs) are highly promising Lewis acid catalysts; they either inherently possess Lewis acid sites (LASs) on it or the LASs can be generated through various post‐synthetic methods, the later can be performed in MOFs in a trivial fashion. MOFs are suitable platform for catalysis because of its highly crystalline and porous nature. Moreover, with recent advancements, thermal and chemical stability is not a problem with many MOFs. In this Minireview, an enormous versatility of MOFs, in terms of their microporosity/mesoporosity, size/shape selectivity, chirality, pore size, etc., has been highlighted. These are advantageous for designing and performing various targeted organic transformations. Although, many organic transformations catalyzed by MOFs with LASs have been reported in the recent past. In this Minireview, we have restricted ourselves to four important organic reactions: (i) cyanosilylation, (ii) Diels–Alder reaction, (iii) C?H activation, and (iv) CO₂‐addition. The discussion focuses mostly on the recent reports (42 examples).